Corrigendum to “Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists”: [Bioorg. Med. Chem. Lett. 15 (2005) 645]

Laura C. Meurer,* Paul E. Finke, Sander G. Mills, Thomas F. Walsh, Richard B. Toupence, John S. Debenham, Mark T. Goulet, Junying Wang, Xinchun Tong, Tung M. Fong, Julie Lao, Marie-Therese Schaeffer, Jing Chen, Chun-Pyn Shen, D. Sloan Stribling, Lauren P. Shearman, Alison M. Strack and Lex H. T. Van der Ploeg Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA Department of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA Department of Pharmacology, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA